We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Despite Concerns About Study in Russia, Panel Backs Vivitrol
Despite Concerns About Study in Russia, Panel Backs Vivitrol
September 29, 2010
Although questions were raised about the Russian population studied in the single trial supporting a new use for Alkermes’ Vivitrol, an FDA advisory panel voted 12–1 to recommend approval of the drug for opioid dependence.